SARS-CoV-2: What do we know so far?

Khedkar, Pratik H; Patzak, Andreas

Khedkar, Pratik H; Patzak, Andreas.

Khedkar PH; Institut für Vegetative Physiologie, Charité - Universitätsmedizin Berlin, corporate member of the Freie Universität Berlin, Humboldt Universität zu Berlin and the Berlin Institute of Health, Berlin, Germany.
Patzak A; Institut für Vegetative Physiologie, Charité - Universitätsmedizin Berlin, corporate member of the Freie Universität Berlin, Humboldt Universität zu Berlin and the Berlin Institute of Health, Berlin, Germany.

Acta Physiol (Oxf) ; 229(2): e13470, 2020 06.

Article in English | MEDLINE | ID: covidwho-2266249

Subject(s)

Betacoronavirus/physiology; Coronavirus Infections/virology; Pneumonia, Viral/virology; Antiviral Agents/chemistry; Antiviral Agents/therapeutic use; Betacoronavirus/growth & development; COVID-19; Coronavirus Infections/epidemiology; Coronavirus Infections/therapy; Coronavirus Infections/transmission; Humans; Immunity, Herd; Pandemics; Pneumonia, Viral/epidemiology; Pneumonia, Viral/therapy; Pneumonia, Viral/transmission; SARS-CoV-2; Viral Vaccines/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Acta Physiol (Oxf) Journal subject: Physiology Year: 2020 Document Type: Article Affiliation country: Apha.13470

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google